Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 825039, 13 pages
http://dx.doi.org/10.1155/2014/825039
Review Article

Progress in the Identification of Dengue Virus Entry/Fusion Inhibitors

1Center for Cellular and Molecular Biology of Diseases, Institute for Scientific Research and Technology Services (INDICASAT-AIP), P.O. Box 0843-01103, City of Panama, Panama
2Department of Biotechnology, Acharya Nagarjuna University, Nagarjuna Nagar, Andhra Pradesh 522 510, India

Received 13 January 2014; Accepted 9 May 2014; Published 24 July 2014

Academic Editor: Christophe N. Peyrefitte

Copyright © 2014 Carolina De La Guardia and Ricardo Lleonart. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, “Treatment, prevention and control global strategy for dengue prevention and control,” 2012.
  2. N. E. A. Murray, M. B. Quam, and A. Wilder-Smith, “Epidemiology of dengue: past, present and future prospects,” Clinical Epidemiology, vol. 5, no. 1, pp. 299–309, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Caminade, J. M. Medlock, E. Ducheyne et al., “Suitability of European climate for the Asian tiger mosquito Aedes albopictus: recent trends and future scenarios,” Journal of the Royal Society Interface, vol. 9, no. 75, pp. 2708–2717, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. O. J. Brady, P. W. Gething, S. Bhatt et al., “Refining the global spatial limits of dengue virus transmission by evidence-based consensus,” PLoS Neglected Tropical Diseases, vol. 6, no. 8, Article ID e1760, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. Centers for Disease Control and Prevention, “Dengue—chapter 3—2014 Yellow Book|Travelers’ Health|CDC,” in CDC Health Information for International Travel 2014, Oxford University Press, New York, NY, USA, 2014. View at Google Scholar
  6. WHO, “WHO: dengue and severe dengue,” Fact Sheet No. 117, 2012, http://www.who.int/mediacentre/factsheets/fs117/en/. View at Google Scholar
  7. S. Bhatt, P. W. Gething, O. J. Brady et al., “The global distribution and burden of dengue,” Nature, vol. 496, no. 7446, pp. 504–507, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. R. J. Kuhn, W. Zhang, M. G. Rossmann et al., “Structure of dengue virus: implications for flavivirus organization, maturation, and fusion,” Cell, vol. 108, no. 5, pp. 717–725, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Lindenbach, T. Heinz-Jürgen, and C. Rice, “Flaviviridae: the viruses and their replication,” in Fields Virology, D. Knipe and P. Howley, Eds., pp. 1103–1152, Lippincott-Raven, Philadelphia, Pa, USA, 5th edition, 2007. View at Google Scholar
  10. X. Zhang, P. Ge, X. Yu et al., “Cryo-EM structure of the mature dengue virus at 3.5-Å resolution,” Nature Structural & Molecular Biology, vol. 20, no. 1, pp. 105–110, 2012. View at Google Scholar
  11. C. T. Jones, L. Ma, J. W. Burgner, T. D. Groesch, C. B. Post, and R. J. Kuhn, “Flavivirus capsid is a dimeric alpha-helical protein,” Journal of Virology, vol. 77, no. 12, pp. 7143–7149, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Ma, C. T. Jones, T. D. Groesch, R. J. Kuhn, and C. B. Post, “Solution structure of dengue virus capsid protein reveals another fold,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 10, pp. 3414–3419, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Perera-Lecoin, L. Meertens, X. Carnec, and A. Amara, “Flavivirus entry receptors: an update,” Viruses, vol. 6, no. 1, pp. 69–88, 2014. View at Publisher · View at Google Scholar
  14. E. G. Acosta, V. Castilla, and E. B. Damonte, “Alternative infectious entry pathways for dengue virus serotypes into mammalian cells,” Cellular Microbiology, vol. 11, no. 10, pp. 1533–1549, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Hase, P. L. Summers, and K. H. Eckels, “Flavivirus entry into cultured mosquito cells and human peripheral blood monocytes,” Archives of Virology, vol. 104, no. 1-2, pp. 129–143, 1989. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Y. Lim and M. L. Ng, “A different mode of entry by dengue-2 neutralisation escape mutant virus,” Archives of Virology, vol. 144, no. 5, pp. 989–995, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Modis, S. Ogata, D. Clements, and S. C. Harrison, “Structure of the dengue virus envelope protein after membrane fusion,” Nature, vol. 427, no. 6972, pp. 313–319, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Zhang, W. Zhang, S. Ogata et al., “Conformational changes of the flavivirus E glycoprotein,” Structure, vol. 12, no. 9, pp. 1607–1618, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. H. M. van der Schaar, M. J. Rust, B. Waarts et al., “Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking,” Journal of Virology, vol. 81, no. 21, pp. 12019–12028, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Cui, M. Raymond, and C.-L. Qiao, “Insecticide resistance in vector mosquitoes in China,” Pest Management Science, vol. 62, no. 11, pp. 1013–1022, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. D. D. Thomas, C. A. Donnelly, R. J. Wood, and L. S. Alphey, “Insect population control using a dominant, repressible, lethal genetic system,” Science, vol. 287, no. 5462, pp. 2474–2476, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Alphey and M. Andreasen, “Dominant lethality and insect population control,” Molecular and Biochemical Parasitology, vol. 121, no. 2, pp. 173–178, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Phuc, M. H. Andreasen, R. S. Burton et al., “Late-acting dominant lethal genetic systems and mosquito control,” BMC Biology, vol. 5, article 11, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Takada and Y. Kawaoka, “Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications,” Reviews in Medical Virology, vol. 13, no. 6, pp. 387–398, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. S. C. Kliks, A. Nisalak, W. E. Brandt, L. Wahl, and D. S. Burke, “Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever,” The American Journal of Tropical Medicine and Hygiene, vol. 40, no. 4, pp. 444–451, 1989. View at Google Scholar · View at Scopus
  26. J. G. Rigau-Pérez, G. G. Clark, D. J. Gubler, P. Reiter, E. J. Sanders, and A. V. Vorndam, “Dengue and dengue haemorrhagic fever,” The Lancet, vol. 352, no. 9132, pp. 971–977, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. S. B. Halstead, “Dengue,” The Lancet, vol. 370, no. 9599, pp. 1644–1652, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. A. T. A. Mairuhu, J. Wagenaar, D. P. M. Brandjes, and E. C. M. Van Gorp, “Dengue: an arthropod-borne disease of global importance,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 23, no. 6, pp. 425–433, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. B. E. E. Martina, P. Koraka, and A. D. M. E. Osterhaus, “Dengue virus pathogenesis: an integrated view,” Clinical Microbiology Reviews, vol. 22, no. 4, pp. 564–581, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Pugach, T. J. Ketas, E. Michael, and J. P. Moore, “Neutralizing antibody and anti-retroviral drug sensitivities of HIV-1 isolates resistant to small molecule CCR5 inhibitors,” Virology, vol. 377, no. 2, pp. 401–407, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. J. P. Lalezari, K. Henry, M. O'Hearn et al., “Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America,” The New England Journal of Medicine, vol. 348, no. 22, pp. 2175–2185, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Volz, L. Allweiss, M. B. Barek et al., “The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus,” Journal of Hepatology, vol. 58, no. 5, pp. 861–867, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Bressanelli, K. Stiasny, S. L. Allison et al., “Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation,” The EMBO Journal, vol. 23, no. 4, pp. 728–738, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. F. A. Rey, F. X. Heinz, C. Mandl, C. Kunz, and S. C. Harrison, “The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution,” Nature, vol. 375, no. 6529, pp. 291–298, 1995. View at Publisher · View at Google Scholar · View at Scopus
  35. W. Zhang, P. R. Chipman, J. Corver et al., “Visualization of membrane protein domains by cryo-electron microscopy of dengue virus,” Nature Structural Biology, vol. 10, no. 11, pp. 907–912, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Modis, S. Ogata, D. Clements, and S. C. Harrison, “A ligand-binding pocket in the dengue virus envelope glycoprotein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 12, pp. 6986–6991, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. S. L. Allison, J. Schalich, K. Stiasny, C. W. Mandl, and F. X. Heinz, “Mutational evidence for an internal fusion peptide in flavivirus envelope protein E,” Journal of Virology, vol. 75, no. 9, pp. 4268–4275, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. S. L. Allison, K. Stiasny, K. Stadler, C. W. Mandl, and F. X. Heinz, “Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E,” Journal of Virology, vol. 73, no. 7, pp. 5605–5612, 1999. View at Google Scholar · View at Scopus
  39. J. Hung, M. Hsieh, M. Young, C. Kao, C. King, and W. Chang, “An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells,” Journal of Virology, vol. 78, no. 1, pp. 378–388, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. D. E. Volk, Y.-C. Lee, X. Li et al., “Solution structure of the envelope protein domain III of dengue-4 virus,” Virology, vol. 364, no. 1, pp. 147–154, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Huang, M. Lee, C. Wu, H. Lei, and J. Cheng, “Solution structure and neutralizing antibody binding studies of domain III of the dengue-2 virus envelope protein,” Proteins: Structure, Function and Genetics, vol. 70, no. 3, pp. 1116–1119, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. R. O. S. Soares and A. Caliri, “Stereochemical features of the envelope protein Domain III of dengue virus reveals putative antigenic site in the five-fold symmetry axis,” Biochimica et Biophysica Acta: Proteins and Proteomics, vol. 1834, no. 1, pp. 221–230, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. M. de Wispelaere and P. L. Yang, “Mutagenesis of the DI/DIII linker in dengue virus envelope protein impairs viral particle assembly,” Journal of Virology, vol. 86, no. 13, pp. 7072–7083, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Butrapet, T. Childers, K. J. Moss et al., “Amino acid changes within the E protein hinge region that affect dengue virus type 2 infectivity and fusion,” Virology, vol. 413, no. 1, pp. 118–127, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. D. Watterson, B. Kobe, and P. R. Young, “Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding,” Journal of General Virology, vol. 93, no. 1, pp. 72–82, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Liao and M. Kielian, “Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus membrane fusion,” Journal of Cell Biology, vol. 171, no. 1, pp. 111–120, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. S. L. Allison, J. Schalich, K. Stiasny, C. W. Mandl, C. Kunz, and F. X. Heinz, “Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH,” Journal of Virology, vol. 69, no. 2, pp. 695–700, 1995. View at Google Scholar · View at Scopus
  48. K. Stiasny, S. L. Allison, A. Marchler-Bauer, C. Kunz, and F. X. Heinz, “Structural requirements for low-pH-induced rearrangements in the envelope glycoprotein of tick-borne encephalitis virus,” Journal of Virology, vol. 70, no. 11, pp. 8142–8147, 1996. View at Google Scholar · View at Scopus
  49. H. M. van der Schaar, M. J. Rust, H. van der Ende-Metselaar, J. Wilschut, X. Zhuang, and J. M. Smit, “Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells,” PLoS Pathogens, vol. 4, no. 12, Article ID e1000244, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Fritz, K. Stiasny, and F. X. Heinz, “Identification of specific histidines as pH sensors in flavivirus membrane fusion,” Journal of Cell Biology, vol. 183, no. 2, pp. 353–361, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. V. Nayak, M. Dessau, K. Kucera, K. Anthony, M. Ledizet, and Y. Modis, “Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion,” Journal of Virology, vol. 83, no. 9, pp. 4338–4344, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. J. A. Mondotte, P.-Y. Lozach, A. Amara, and A. V. Gamarnik, “Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation,” Journal of Virology, vol. 81, no. 13, pp. 7136–7148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. B. Tassaneetrithep, T. H. Burgess, A. Granelli-Piperno et al., “DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells,” The Journal of Experimental Medicine, vol. 197, no. 7, pp. 823–829, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. E. Navarro-Sanchez, R. Altmeyer, A. Amara et al., “Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses,” EMBO Reports, vol. 4, no. 7, pp. 723–728, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Chen, S. Wang, and C. King, “Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism,” Journal of Virology, vol. 73, no. 4, pp. 2650–2657, 1999. View at Google Scholar · View at Scopus
  56. J. L. Miller, B. J. M. de Wet, L. Martinez-Pomares et al., “The mannose receptor mediates dengue virus infection of macrophages,” PLoS Pathogens, vol. 4, no. 2, article e17, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Reyes-del Valle, S. Chávez-Salinas, F. Medina, and R. M. del Angel, “Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells,” Journal of Virology, vol. 79, no. 8, pp. 4557–4567, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Jindadamrongwech, C. Thepparit, and D. R. Smith, “Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2,” Archives of Virology, vol. 149, no. 5, pp. 915–927, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. C. Thepparit and D. R. Smith, “Serotype-specific entry of dengue virus into liver cells: identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor,” Journal of Virology, vol. 78, no. 22, pp. 12647–12656, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. L. Meertens, X. Carnec, M. P. Lecoin et al., “The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry,” Cell Host and Microbe, vol. 12, no. 4, pp. 544–557, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Zhang, J. Wang, N. Gao, Z. Chen, Y. Tian, and J. An, “Up-regulated expression of β3 integrin induced by dengue virus serotype 2 infection associated with virus entry into human dermal microvascular endothelial cells,” Biochemical and Biophysical Research Communications, vol. 356, no. 3, pp. 763–768, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. Y. Li, C. Kakinami, Q. Li, B. Yang, and H. Li, “Human apolipoprotein A-I is associated with dengue virus and enhances virus infection through SR-BI,” PLoS ONE, vol. 8, no. 7, Article ID e70390, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. F. Gao, X. Duan, X. Lu et al., “Novel binding between pre-membrane protein and claudin-1 is required for efficient dengue virus entry,” Biochemical and Biophysical Research Communications, vol. 391, no. 1, pp. 952–957, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. P. Che, H. Tang, and Q. Li, “The interaction between claudin-1 and dengue viral prM/M protein for its entry,” Virology, vol. 446, no. 1-2, pp. 303–313, 2013. View at Publisher · View at Google Scholar
  65. O. Hershkovitz, B. Rosental, L. A. Rosenberg et al., “NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells,” The Journal of Immunology, vol. 183, no. 4, pp. 2610–2621, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. J. de Jesús Martínez-Barragán and R. M. del Angel, “Identification of a putative coreceptor on Vero cells that participates in dengue 4 virus infection,” Journal of Virology, vol. 75, no. 17, pp. 7818–7827, 2001. View at Publisher · View at Google Scholar · View at Scopus
  67. T. B. H. Geijtenbeek and Y. Van Kooyk, “Pathogens target DC-SIGN to influence their fate: DC-SIGN functions as a pathogen receptor with broad specificity,” APMIS, vol. 111, no. 7-8, pp. 698–714, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. T. B. H. Geijtenbeek, D. S. Kwon, R. Torensma et al., “DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells,” Cell, vol. 100, no. 5, pp. 587–597, 2000. View at Publisher · View at Google Scholar · View at Scopus
  69. C. P. Alvarez, F. Lasala, J. Carrillo, O. Muñiz, A. L. Corbí, and R. Delgado, “C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola Virus in cis and in trans,” Journal of Virology, vol. 76, no. 13, pp. 6841–6844, 2002. View at Publisher · View at Google Scholar · View at Scopus
  70. F. Halary, A. Amara, H. Lortat-Jacob et al., “Human Cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection,” Immunity, vol. 17, no. 5, pp. 653–664, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. P.-Y. Lozach, L. Burleigh, I. Staropoli et al., “Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals,” The Journal of Biological Chemistry, vol. 280, no. 25, pp. 23698–23708, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Shah, A. Wadood, Z. Rahman, and T. Husnain, “Interaction and inhibition of dengue envelope glycoprotein with mammalian receptor DC-Sign, an in-silico approach,” PLoS ONE, vol. 8, no. 3, Article ID e59211, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. M. M. F. Alen, T. de Burghgraeve, S. J. F. Kaptein, J. Balzarini, J. Neyts, and D. Schols, “Broad Antiviral activity of Carbohydrate-binding agents against the four serotypes of dengue virus in monocyte-derived dendritic cells,” PLoS ONE, vol. 6, no. 6, Article ID e21658, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. J. D. Esko and S. B. Selleck, “Order out of chaos: assembly of ligand binding sites in heparan sulfate,” Annual Review of Biochemistry, vol. 71, pp. 435–471, 2002. View at Publisher · View at Google Scholar · View at Scopus
  75. Y. Chen, T. Maguire, R. E. Hileman et al., “Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate,” Nature Medicine, vol. 3, no. 8, pp. 866–871, 1997. View at Publisher · View at Google Scholar · View at Scopus
  76. P. Hilgard and R. Stockert, “Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes,” Hepatology, vol. 32, no. 5, pp. 1069–1077, 2000. View at Publisher · View at Google Scholar · View at Scopus
  77. S. L. Hung, P. L. Lee, H. W. Chen, L. K. Chen, C. C. Kao, and C. King, “Analysis of the steps involved in dengue virus entry into host cells,” Virology, vol. 257, no. 1, pp. 156–167, 1999. View at Publisher · View at Google Scholar · View at Scopus
  78. L. B. Talarico, M. D. Noseda, D. R. B. Ducatti, M. E. R. Duarte, and E. B. Damonte, “Differential inhibition of dengue virus infection in mammalian and mosquito cells by iota-carrageenan,” Journal of General Virology, vol. 92, no. 6, pp. 1332–1342, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. K. Boonnak, B. M. Slike, T. H. Burgess et al., “Role of dendritic cells in antibody-dependent enhancement of dengue virus infection,” Journal of Virology, vol. 82, no. 8, pp. 3939–3951, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. S. Bhattacharyya, A. Zagórska, E. D. Lew et al., “Enveloped viruses disable innate immune responses in dendritic cells by direct activation of TAM receptors,” Cell Host and Microbe, vol. 14, no. 2, pp. 136–147, 2013. View at Publisher · View at Google Scholar · View at Scopus
  81. D. Kato, S. Era, I. Watanabe et al., “Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein,” Antiviral Research, vol. 88, no. 2, pp. 236–243, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. C. O. Nicholson, J. M. Costin, D. K. Rowe et al., “Viral entry inhibitors block dengue antibody-dependent enhancement in vitro,” Antiviral Research, vol. 89, no. 1, pp. 71–74, 2011. View at Publisher · View at Google Scholar · View at Scopus
  83. S. Lin, G. Zou, S. Hsieh et al., “The helical domains of the stem region of dengue virus envelope protein are involved in both virus assembly and entry,” Journal of Virology, vol. 85, no. 10, pp. 5159–5171, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. Y. M. Hrobowski, R. F. Garry, and S. F. Michael, “Peptide inhibitors of dengue virus and West Nile virus infectivity,” Virology Journal, vol. 2, article 49, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. S. Lok, J. M. Costin, Y. M. Hrobowski et al., “Release of dengue virus genome induced by a peptide inhibitor,” PLoS ONE, vol. 7, no. 11, Article ID e50995, 2012. View at Publisher · View at Google Scholar · View at Scopus
  86. A. G. Schmidt, P. L. Yang, and S. C. Harrison, “Peptide inhibitors of flavivirus entry derived from the E protein stem,” Journal of Virology, vol. 84, no. 24, pp. 12549–12554, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. A. G. Schmidt, K. Lee, P. L. Yang, and S. C. Harrison, “Small-molecule inhibitors of dengue-virus entry,” PLoS Pathogens, vol. 8, no. 4, Article ID e1002627, 2012. View at Publisher · View at Google Scholar · View at Scopus
  88. J.-M. Yang, Y.-F. Chen, Y.-Y. Tu, K.-R. Yen, and Y.-L. Yang, “Combinatorial computational approaches to identify tetracycline derivatives as flavivirus inhibitors,” PLoS ONE, vol. 2, no. 5, article e428, 2007. View at Publisher · View at Google Scholar · View at Scopus
  89. S. J. F. Kaptein, T. De Burghgraeve, M. Froeyen et al., “A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 12, pp. 5269–5280, 2010. View at Publisher · View at Google Scholar · View at Scopus
  90. T. de Burghgraeve, S. J. F. Kaptein, N. V. Ayala-Nunez et al., “An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro,” PLoS ONE, vol. 7, no. 5, Article ID e37244, 2012. View at Publisher · View at Google Scholar · View at Scopus
  91. Q.-Y. Wang, S. J. Patel, E. Vangrevelinghe et al., “A small-molecule dengue virus entry inhibitor,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 5, pp. 1823–1831, 2009. View at Publisher · View at Google Scholar · View at Scopus
  92. M. K. Poh, A. Yip, S. Zhang et al., “A small molecule fusion inhibitor of dengue virus,” Antiviral Research, vol. 84, no. 3, pp. 260–266, 2009. View at Publisher · View at Google Scholar · View at Scopus
  93. T. Kampmann, R. Yennamalli, P. Campbell et al., “In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses,” Antiviral Research, vol. 84, no. 3, pp. 234–241, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. Z. Li, M. Khaliq, Z. Zhou, C. B. Post, R. J. Kuhn, and M. Cushman, “Design, synthesis, and biological evaluation of antiviral agents targeting flavivirus envelope proteins,” Journal of Medicinal Chemistry, vol. 51, no. 15, pp. 4660–4671, 2008. View at Publisher · View at Google Scholar · View at Scopus
  95. Z. Zhou, M. Khaliq, J. Suk et al., “Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein,” ACS Chemical Biology, vol. 3, no. 12, pp. 765–775, 2008. View at Publisher · View at Google Scholar · View at Scopus
  96. J. M. Costin, E. Jenwitheesuk, S. Lok et al., “Structural optimization and de novo design of dengue virus entry inhibitory peptides,” PLoS Neglected Tropical Diseases, vol. 4, no. 6, article e721, 2010. View at Publisher · View at Google Scholar · View at Scopus
  97. J. F. L. Chin, J. J. H. Chu, and M. L. Ng, “The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry,” Microbes and Infection, vol. 9, no. 1, pp. 1–6, 2007. View at Publisher · View at Google Scholar · View at Scopus
  98. M. A. Alhoot, A. K. Rathinam, S. M. Wang, R. Manikam, and S. D. Sekaran, “Inhibition of dengue virus entry into target cells using synthetic antiviral peptides,” International Journal of Medical Sciences, vol. 10, no. 6, pp. 719–729, 2013. View at Publisher · View at Google Scholar · View at Scopus
  99. K. I. P. J. Hidari, N. Takahashi, M. Arihara, M. Nagaoka, K. Morita, and T. Suzuki, “Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga,” Biochemical and Biophysical Research Communications, vol. 376, no. 1, pp. 91–95, 2008. View at Publisher · View at Google Scholar · View at Scopus
  100. Y. Kaneko, O. Yoshida, R. Nakagawa et al., “Inhibition of HIV-1 infectivity with curdlan sulfate in vitro,” Biochemical Pharmacology, vol. 39, no. 4, pp. 793–797, 1990. View at Publisher · View at Google Scholar · View at Scopus
  101. K. Ichiyama, S. B. Gopala Reddy, L. F. Zhang et al., “Sulfated polysaccharide, curdlan sulfate, efficiently prevents entry/fusion and restricts antibody-dependent enhancement of dengue virus infection in vitro: a possible candidate for clinical application,” PLoS Neglected Tropical Diseases, vol. 7, no. 4, Article ID e2188, 2013. View at Publisher · View at Google Scholar · View at Scopus
  102. C. A. Pujol, S. Ray, B. Ray, and E. B. Damonte, “Antiviral activity against dengue virus of diverse classes of algal sulfated polysaccharides,” International Journal of Biological Macromolecules, vol. 51, no. 4, pp. 412–416, 2012. View at Publisher · View at Google Scholar · View at Scopus
  103. L. B. Talarico, C. A. Pujol, R. G. M. Zibetti et al., “The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell,” Antiviral Research, vol. 66, no. 2-3, pp. 103–110, 2005. View at Publisher · View at Google Scholar · View at Scopus
  104. P. Vervaeke, M. Alen, S. Noppen, D. Schols, P. Oreste, and S. Liekens, “Sulfated escherichia coli K5 polysaccharide derivatives inhibit dengue virus infection of human microvascular endothelial cells by interacting with the viral envelope protein E domain III,” PLoS ONE, vol. 8, no. 8, Article ID e74035, 2013. View at Publisher · View at Google Scholar · View at Scopus
  105. E. Lee, M. Pavy, N. Young, C. Freeman, and M. Lobigs, “Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses,” Antiviral Research, vol. 69, no. 1, pp. 31–38, 2006. View at Publisher · View at Google Scholar · View at Scopus
  106. L. Ono, W. Wollinger, I. M. Rocco, T. L. M. Coimbra, P. A. J. Gorin, and M. Sierakowski, “In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain),” Antiviral Research, vol. 60, no. 3, pp. 201–208, 2003. View at Publisher · View at Google Scholar · View at Scopus
  107. N. V. Ayala-Nuñez, P. Jarupathirun, S. J. F. Kaptein, J. Neyts, and J. M. Smit, “Antibody-dependent enhancement of dengue virus infection is inhibited by SA-17, a doxorubicin derivative,” Antiviral Research, vol. 100, no. 1, pp. 238–245, 2013. View at Google Scholar
  108. L.-T. Lin, T.-Y. Chen, S.-C. Lin et al., “Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry,” BMC Microbiology, vol. 13, no. 1, article 187, 2013. View at Publisher · View at Google Scholar · View at Scopus
  109. C. M. Byrd, D. Dai, D. W. Grosenbach et al., “A novel inhibitor of dengue virus replication that targets the capsid protein,” Antimicrobial Agents and Chemotherapy, vol. 57, no. 1, pp. 15–25, 2013. View at Publisher · View at Google Scholar · View at Scopus
  110. C. R. Rees, J. M. Costin, R. C. Fink et al., “In vitro inhibition of dengue virus entry by p-sulfoxy-cinnamic acid and structurally related combinatorial chemistries,” Antiviral Research, vol. 80, no. 2, pp. 135–142, 2008. View at Publisher · View at Google Scholar · View at Scopus
  111. J. T. Roehrig, R. A. Bolin, and R. G. Kelly, “Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica,” Virology, vol. 246, no. 2, pp. 317–328, 1998. View at Publisher · View at Google Scholar · View at Scopus
  112. S. Lok, V. Kostyuchenko, G. E. Nybakken et al., “Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins,” Nature Structural and Molecular Biology, vol. 15, no. 3, pp. 312–317, 2008. View at Publisher · View at Google Scholar · View at Scopus
  113. W. D. Crill and J. T. Roehrig, “Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to vero cells,” Journal of Virology, vol. 75, no. 16, pp. 7769–7773, 2001. View at Publisher · View at Google Scholar · View at Scopus
  114. B. Shrestha, J. D. Brien, S. Sukupolvi-Petty et al., “The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1,” PLoS Pathogens, vol. 6, no. 4, Article ID e1000823, pp. 1–18, 2010. View at Google Scholar · View at Scopus
  115. A. P. Goncalvez, R. E. Engle, M. St. Claire, R. H. Purcell, and C. Lai, “Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 22, pp. 9422–9427, 2007. View at Publisher · View at Google Scholar · View at Scopus
  116. W.-K. Wang, D.-Y. Chao, C.-L. Kao et al., “High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis,” Virology, vol. 305, no. 2, pp. 330–338, 2003. View at Publisher · View at Google Scholar · View at Scopus
  117. M. A. Alhoot, S. M. Wang, and S. D. Sekaran, “Inhibition of dengue virus entry and multiplication into monocytes using RNA interference,” PLoS Neglected Tropical Diseases, vol. 5, no. 11, Article ID e1410, 2011. View at Publisher · View at Google Scholar · View at Scopus
  118. M. A. Alhoot, S. M. Wang, and S. D. Sekaran, “RNA interference mediated inhibition of dengue virus multiplication and entry in HepG2 cells,” PLoS ONE, vol. 7, no. 3, Article ID e34060, 2012. View at Publisher · View at Google Scholar · View at Scopus
  119. D. H. Libraty, T. P. Endy, H.-S. H. Houng et al., “Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections,” Journal of Infectious Diseases, vol. 185, no. 9, pp. 1213–1221, 2002. View at Publisher · View at Google Scholar · View at Scopus
  120. J. Fink, F. Gu, L. Ling et al., “Host gene expression profiling of dengue virus infection in cell lines and patients,” PLoS Neglected Tropical Diseases, vol. 1, no. 2, article e86, 2007. View at Publisher · View at Google Scholar · View at Scopus
  121. S. Zompi and E. Harris, “Animal models of dengue virus infection,” Viruses, vol. 4, no. 1, pp. 62–82, 2012. View at Publisher · View at Google Scholar · View at Scopus
  122. S. Watanabe, A. P. S. Rathore, C. Sung et al., “Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial,” Antiviral Research, vol. 96, no. 1, pp. 32–35, 2012. View at Publisher · View at Google Scholar · View at Scopus
  123. S. T. Perry, M. D. Buck, E. M. Plummer et al., “An iminosugar with potent inhibition of dengue virus infection in vivo,” Antiviral Research, vol. 98, no. 1, pp. 35–43, 2013. View at Publisher · View at Google Scholar · View at Scopus
  124. D. A. Bente, M. W. Melkus, J. V. Garcia, and R. Rico-Hesse, “Dengue fever in humanized NOD/SCID mice,” Journal of Virology, vol. 79, no. 21, pp. 13797–13799, 2005. View at Publisher · View at Google Scholar · View at Scopus
  125. J. Mota and R. Rico-Hesse, “Humanized mice show clinical signs of dengue fever according to infecting virus genotype,” Journal of Virology, vol. 83, no. 17, pp. 8638–8645, 2009. View at Publisher · View at Google Scholar · View at Scopus
  126. J. Cox, J. Mota, S. Sukupolvi-Petty, M. S. Diamond, and R. Rico-Hesse, “Mosquito bite delivery of dengue virus enhances immunogenicity and pathogenesis in humanized mice,” Journal of Virology, vol. 86, no. 14, pp. 7637–7649, 2012. View at Publisher · View at Google Scholar · View at Scopus